---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-059489"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2021-11-15T23:59:59+00:00"
generated_at: "2026-06-28T08:51:15.913387+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Nektar Therapeutics appoints Diana M. Brainard, M.D. to board of directors

## Summary
- Dr. Brainard appointed as Class III Director effective Nov 11, 2021; term expires at 2022 annual meeting.
- Board determined she is independent under SEC and Nasdaq rules.
- She receives standard non-employee director compensation: initial option for 36,720 shares vesting over 3 years, RSU for 18,360 shares vesting over 3 years, and $65,000 annual cash retainer.

## SEC filing metadata
- accession: 0001213900-21-059489
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2021-11-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000121390021059489/0001213900-21-059489-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000121390021059489/ea150696-8k_nektartherap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-059489
- JSON: https://secwatch.observer/filing/0001213900-21-059489.json
- Plain text: https://secwatch.observer/filing/0001213900-21-059489.txt

## Key facts
- Executive change
  Diana M. Brainard, M.D. was appointed as Class III Director at NEKTAR THERAPEUTICS.
  - Action: appointed
  - Role: Class III Director
  source text: On November 11, 2021, Diana M. Brainard, M.D. was appointed to the board of directors (the “ Board ”) of Nektar Therapeutics, a Delaware corporation (the “ Company ”), as a Class III Director
  evidence_url: https://www.sec.gov/Archives/edgar/data/906709/000121390021059489/0001213900-21-059489-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.